Generation Bio Return on Tangible Equity 2020-2023 | GBIO
Current and historical return on tangible equity values for Generation Bio (GBIO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Generation Bio Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$-0.13B |
$0.20B |
-52.07% |
| 2023-09-30 |
$-0.12B |
$0.23B |
-46.99% |
| 2023-06-30 |
$-0.13B |
$0.25B |
-44.84% |
| 2023-03-31 |
$-0.13B |
$0.28B |
-44.52% |
| 2022-12-31 |
$-0.14B |
$0.28B |
-42.87% |
| 2022-09-30 |
$-0.14B |
$0.31B |
-39.44% |
| 2022-06-30 |
$-0.14B |
$0.33B |
-37.08% |
| 2022-03-31 |
$-0.13B |
$0.35B |
-32.76% |
| 2021-12-31 |
$-0.12B |
$0.38B |
-28.55% |
| 2021-09-30 |
$-0.11B |
$0.41B |
-28.84% |
| 2021-06-30 |
$-0.10B |
$0.43B |
-28.20% |
| 2021-03-31 |
$-0.09B |
$0.46B |
-27.01% |
| 2020-12-31 |
$-0.08B |
$0.27B |
-37.72% |
| 2020-06-30 |
$-0.05B |
$0.30B |
-68.42% |
| 2020-03-31 |
$-0.05B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.211B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
